Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGF<i>β</i>1‐induced macrophages
Camila Maria Longo Machado(Universidade de São Paulo), Roger Chammas(Universidade de São Paulo), Suely Nonogaki(Instituto Adolfo Lutz), Emerson Soares Bernardes(Nuclear Engineering Institute), Anamaria A. Camargo(Hospital Sírio-Libanês), Camila Morais Melo(Universidade de São Paulo), Verônica R. Teixeira(Universidade de São Paulo), Fabrício F. Costa(Northwestern University), Fu‐Tong Liu(University of Southern California), Sofia Nascimento dos Santos(Instituto de Pesquisas Energéticas e Nucleares), Luciana Nogueira de Sousa Andrade(Universidade de São Paulo)
Cited by 48
Related Papers
Galectins: structure, function and therapeutic potential
|Expert Reviews in Molecular Medicine|2008|861
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
|Trends in Immunology|2002|530
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
|Nucleic Acids Research|2008|440
Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis
|The Journal of Immunology|2009|187
Toxoplasma gondii Infection Reveals a Novel Regulatory Role for Galectin-3 in the Interface of Innate and Adaptive Immunity
|American Journal Of Pathology|2006|142